DrugPatentWatch Database Preview
Details for Patent: 9,526,703
» See Plans and Pricing
Which drugs does patent 9,526,703 protect, and when does it expire?
Patent 9,526,703 protects BONJESTA and is included in one NDA.
This patent has twenty-nine patent family members in twenty-four countries.
Summary for Patent: 9,526,703
| Title: | Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| Abstract: | A solid oral dosage form comprising a core comprising a doxylamine component and a pyridoxine component coated with an enteric coating is disclosed. The solid oral dosage form further comprises two active ingredient-containing coatings surrounding the enteric coating, the active ingredient-containing coatings being separated from one another by an intermediate coating, and one of the two active ingredient-containing coatings comprising a doxylamine component and being free of a pyridoxine component, and the other of the two active ingredient-containing coatings comprising a pyridoxine component and being free of doxylamine component. Uses of the solid oral dosage form for the alleviation of the symptoms of nausea and vomiting, for example in the case of nausea and vomiting of pregnancy (NVP), are also disclosed. |
| Inventor(s): | Vranderick; Manon (St-Lazare, CA), St-Onge; Jean-Luc (Mirabel, CA), Gallo; Michele (Blainville, CA), Gervais; Eric (Blainville, CA) |
| Assignee: | Duchesnay Inc. (Blainville, CA) |
| Application Number: | 14/839,859 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Dosage form; |
Drugs Protected by US Patent 9,526,703
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Duchesnay | BONJESTA | doxylamine succinate; pyridoxine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209661-001 | Nov 7, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,526,703
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| PCT/CA2014/050828 | Aug 29, 2014 | |
International Family Members for US Patent 9,526,703
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 101728 | Start Trial | |||
| Australia | 2014405049 | Start Trial | |||
| Brazil | 112017004190 | Start Trial | |||
| Canada | 2920247 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
